HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immature truncated O-glycophenotype of cancer directly induces oncogenic features.

Abstract
Aberrant expression of immature truncated O-glycans is a characteristic feature observed on virtually all epithelial cancer cells, and a very high frequency is observed in early epithelial premalignant lesions that precede the development of adenocarcinomas. Expression of the truncated O-glycan structures Tn and sialyl-Tn is strongly associated with poor prognosis and overall low survival. The genetic and biosynthetic mechanisms leading to accumulation of truncated O-glycans are not fully understood and include mutation or dysregulation of glycosyltransferases involved in elongation of O-glycans, as well as relocation of glycosyltransferases controlling initiation of O-glycosylation from Golgi to endoplasmic reticulum. Truncated O-glycans have been proposed to play functional roles for cancer-cell invasiveness, but our understanding of the biological functions of aberrant glycosylation in cancer is still highly limited. Here, we used exome sequencing of most glycosyltransferases in a large series of primary and metastatic pancreatic cancers to rule out somatic mutations as a cause of expression of truncated O-glycans. Instead, we found hypermethylation of core 1 β3-Gal-T-specific molecular chaperone, a key chaperone for O-glycan elongation, as the most prevalent cause. We next used gene editing to produce isogenic cell systems with and without homogenous truncated O-glycans that enabled, to our knowledge, the first polyomic and side-by-side evaluation of the cancer O-glycophenotype in an organotypic tissue model and in xenografts. The results strongly suggest that truncation of O-glycans directly induces oncogenic features of cell growth and invasion. The study provides support for targeting cancer-specific truncated O-glycans with immunotherapeutic measures.
AuthorsPrakash Radhakrishnan, Sally Dabelsteen, Frey Brus Madsen, Chiara Francavilla, Katharina L Kopp, Catharina Steentoft, Sergey Y Vakhrushev, Jesper V Olsen, Lars Hansen, Eric P Bennett, Anders Woetmann, Guangliang Yin, Longyun Chen, Haiyan Song, Mads Bak, Ryan A Hlady, Staci L Peters, Rene Opavsky, Christenze Thode, Klaus Qvortrup, Katrine T-B G Schjoldager, Henrik Clausen, Michael A Hollingsworth, Hans H Wandall
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 111 Issue 39 Pg. E4066-75 (Sep 30 2014) ISSN: 1091-6490 [Electronic] United States
PMID25118277 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • C1GALT1C1 protein, human
  • Molecular Chaperones
  • Polysaccharides
Topics
  • Animals
  • Cell Adhesion
  • Cell Differentiation
  • Cell Line, Tumor
  • Cell Proliferation
  • Exome (genetics)
  • Glycomics
  • Glycosylation
  • Heterografts
  • Humans
  • Mice
  • Mice, Knockout
  • Mice, Nude
  • Mice, SCID
  • Molecular Chaperones (chemistry, genetics, metabolism)
  • Mutation
  • Neoplasm Invasiveness
  • Pancreatic Neoplasms (genetics, metabolism, pathology)
  • Phenotype
  • Polysaccharides (chemistry, metabolism)
  • Proteomics
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: